Viking Therapeutics (VKTX) Tops Q3 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• JPMorgan Upgrades Magellan Financial Group (MFG:AU) (MGLLF) to Neutral
• UBS Starts Yushu Technology Co (688836:CH) at Neutral